We have shown that treatment with pevonedistat abrogated the pro-survival effect of the lymph node-mimicking conditions via downmodulation of NFκB signaling and upregulation of the pro-apoptotic BCL2 family proteins BAX and NOXA in resting CLL cells [6, 7]. The gene discussed is NFKB1; the disease is B-cell chronic lymphocytic leukemia.